AU2001255241A1 - Leishmania antigens for use in the therapy and diagnosis of leishmaniasis - Google Patents
Leishmania antigens for use in the therapy and diagnosis of leishmaniasisInfo
- Publication number
- AU2001255241A1 AU2001255241A1 AU2001255241A AU5524101A AU2001255241A1 AU 2001255241 A1 AU2001255241 A1 AU 2001255241A1 AU 2001255241 A AU2001255241 A AU 2001255241A AU 5524101 A AU5524101 A AU 5524101A AU 2001255241 A1 AU2001255241 A1 AU 2001255241A1
- Authority
- AU
- Australia
- Prior art keywords
- leishmaniasis
- diagnosis
- therapy
- leishmania antigens
- leishmania
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000222722 Leishmania <genus> Species 0.000 title 1
- 208000004554 Leishmaniasis Diseases 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/551,974 | 2000-04-14 | ||
US09/551,974 US6500437B1 (en) | 1995-09-22 | 2000-04-14 | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US09/565,501 | 2000-05-05 | ||
US09/565,501 US6607731B1 (en) | 1995-09-22 | 2000-05-05 | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US09/639,206 US6613337B1 (en) | 1997-02-12 | 2000-08-14 | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US09/639,206 | 2000-08-14 | ||
PCT/US2001/011254 WO2001079276A2 (en) | 2000-04-14 | 2001-04-05 | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001255241A1 true AU2001255241A1 (en) | 2001-10-30 |
Family
ID=27415636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001255241A Abandoned AU2001255241A1 (en) | 2000-04-14 | 2001-04-05 | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
Country Status (10)
Country | Link |
---|---|
US (1) | US6613337B1 (en) |
EP (2) | EP1681301B1 (en) |
AR (1) | AR028333A1 (en) |
AT (1) | ATE310746T1 (en) |
AU (1) | AU2001255241A1 (en) |
DE (1) | DE60115230T2 (en) |
ES (2) | ES2255553T3 (en) |
MX (1) | MXPA02010173A (en) |
PT (1) | PT1681301E (en) |
WO (1) | WO2001079276A2 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR200103266T2 (en) * | 1999-05-13 | 2002-01-21 | American Cyanamid Company | Auxiliary combination formulations |
ATE383871T1 (en) * | 2000-02-18 | 2008-02-15 | Vlaams Interuniv Inst Biotech | USE OF OPRI LIPOPROTEIN FROM PSEUDOMONAS AS TH1-INDUCING NATURAL ADJUVANT FOR HETEROLOGUE ANTIGENS |
EE200300172A (en) * | 2000-11-10 | 2003-06-16 | Wyeth Holdings Corporation | An antigenic composition and adjuvant mixture |
US7833534B2 (en) | 2006-04-10 | 2010-11-16 | Infectious Disease Research Institute | Compounds and methods for diagnosis and treatment of leishmaniasis |
EP2170372A1 (en) | 2007-07-13 | 2010-04-07 | Infectious Disease Research Institute | Leishmania sterol 24-c-methyltransferase compositions for the prevention, treatment and diagnosis of leishmaniasis |
US8410258B2 (en) | 2008-05-21 | 2013-04-02 | Infections Disease Research Institute | Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis |
AR073170A1 (en) | 2008-05-21 | 2010-10-20 | Infectious Disease Res Inst | RECOMBINANT POLYPROTEIN VACCINES FOR THE TREATMENT AND DIAGNOSIS OF LEISHMANIASIS |
ES2628743T3 (en) | 2008-07-03 | 2017-08-03 | Infectious Disease Research Institute | Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
BRPI0900961B8 (en) * | 2009-03-23 | 2021-07-13 | Fundacao Oswaldo Cruz | Leishmaniasis diagnostic methods and kit |
RU2558233C2 (en) * | 2009-07-13 | 2015-07-27 | Лабораториос Лети, С.Л. | Diagnostics of parasitic disease, such as leishmaniasis, with application of ribosomal protein extract (rpe) |
WO2014091463A1 (en) * | 2012-12-14 | 2014-06-19 | Universidade Federal De Minas Gerais - Ufmg | Method for producing leishmania recombinant proteins and use in a diagnostic kit and vaccine against leishmaniases |
BR112015024860B1 (en) | 2013-03-28 | 2023-11-07 | Access To Advanced Health Institute | FUSION POLYPEPTIDE, ISOLATED POLYNUCLEOTIDE, COMPOSITION COMPRISING SAID POLYPEPTIDE, USE OF SAID COMPOSITION TO STIMULATE AN IMMUNE RESPONSE AGAINST LEISHMANIA AND IN VITRO METHOD AND DIAGNOSTIC KIT FOR DETECTING LEISHMANIA INFECTION IN A BIOLOGICAL SPECIMEN |
US20140356391A1 (en) * | 2013-05-29 | 2014-12-04 | Jose Antonio O'Daly | Amino acid sequences for clinical remission of psoriasis and related diseases. |
JP2016053535A (en) * | 2014-09-04 | 2016-04-14 | 国立大学法人 東京大学 | Testing reagent or kit for cutaneous leishmaniasis, and testing method of the same |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4870006A (en) | 1986-07-24 | 1989-09-26 | Codon | Antigenic material for a chagas' disease detection system |
US5411865A (en) | 1993-01-15 | 1995-05-02 | Iasys Corporation | Method of detecting anti-leishmania parasite antibodies |
US5961970A (en) | 1993-10-29 | 1999-10-05 | Pharmos Corporation | Submicron emulsions as vaccine adjuvants |
US5571515A (en) | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
ATE206163T1 (en) | 1994-04-22 | 2001-10-15 | Corixa Corp | COMPOUNDS AND METHODS FOR STIMULATING AND INCREASE PROTECTIVE IMMUNE RESPONSES AND IL-12 PRODUCTION |
US6013268A (en) | 1994-04-22 | 2000-01-11 | Corixa Corporation | Methods for enhancement of protective immune responses |
US5876735A (en) | 1994-04-22 | 1999-03-02 | Corixa Corporation | Methods for enhancement of protective immune responses |
US5879687A (en) | 1994-04-22 | 1999-03-09 | Corixa Corporation | Methods for enhancement of protective immune responses |
US5912166A (en) | 1995-04-21 | 1999-06-15 | Corixa Corporation | Compounds and methods for diagnosis of leishmaniasis |
US5965142A (en) | 1995-08-04 | 1999-10-12 | Corixa Corporation | Polypeptides and methods for the detection of L. tropica infection |
US5834592A (en) | 1995-09-22 | 1998-11-10 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis |
US5744593A (en) * | 1996-02-15 | 1998-04-28 | Heska Corporation | Parasitic helminth larval thiol specific antioxidant proteins and nucleic acid molecules |
US5910306A (en) | 1996-11-14 | 1999-06-08 | The United States Of America As Represented By The Secretary Of The Army | Transdermal delivery system for antigen |
US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
US5846748A (en) | 1996-11-15 | 1998-12-08 | The Council Of Scientific & Industrial Research | Method for diagnosing visceral leishmaniasis in a patient by identification of a new key marker namely 9-O-acetylated sialoglycoconjugate |
EP0981624A2 (en) | 1997-02-12 | 2000-03-01 | Corixa Corporation | $i(LEISHMANIA) ANTIGENS FOR USE IN THE THERAPY AND DIAGNOSIS OF LEISHMANIASIS |
ES2326174T3 (en) * | 1998-12-23 | 2009-10-02 | Laboratorios Leti, S.L. | CHEMICAL GENE THAT CODIFIES THE FOUR PROTEIN ANTIGENIC DETERMINANTS OF L. INFANTUM. |
-
2000
- 2000-08-14 US US09/639,206 patent/US6613337B1/en not_active Expired - Lifetime
-
2001
- 2001-04-05 PT PT05025429T patent/PT1681301E/en unknown
- 2001-04-05 AU AU2001255241A patent/AU2001255241A1/en not_active Abandoned
- 2001-04-05 EP EP05025429A patent/EP1681301B1/en not_active Expired - Lifetime
- 2001-04-05 ES ES01928377T patent/ES2255553T3/en not_active Expired - Lifetime
- 2001-04-05 WO PCT/US2001/011254 patent/WO2001079276A2/en active IP Right Grant
- 2001-04-05 MX MXPA02010173A patent/MXPA02010173A/en active IP Right Grant
- 2001-04-05 EP EP01928377A patent/EP1287026B1/en not_active Expired - Lifetime
- 2001-04-05 AT AT01928377T patent/ATE310746T1/en not_active IP Right Cessation
- 2001-04-05 ES ES05025429T patent/ES2391562T3/en not_active Expired - Lifetime
- 2001-04-05 DE DE60115230T patent/DE60115230T2/en not_active Expired - Lifetime
- 2001-04-11 AR ARP010101749A patent/AR028333A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ES2391562T3 (en) | 2012-11-27 |
AR028333A1 (en) | 2003-05-07 |
US6613337B1 (en) | 2003-09-02 |
DE60115230D1 (en) | 2005-12-29 |
EP1681301B1 (en) | 2012-07-18 |
ATE310746T1 (en) | 2005-12-15 |
ES2255553T3 (en) | 2006-07-01 |
WO2001079276A3 (en) | 2002-09-06 |
DE60115230T2 (en) | 2006-08-03 |
PT1681301E (en) | 2012-10-26 |
EP1287026B1 (en) | 2005-11-23 |
MXPA02010173A (en) | 2003-06-04 |
EP1287026A2 (en) | 2003-03-05 |
EP1681301A1 (en) | 2006-07-19 |
WO2001079276A2 (en) | 2001-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1757606E (en) | Xanthinderivatives for use as medical agents and the preparation thereof | |
AU2001236798A1 (en) | Optically-active nanoparticles for use in therapeutic and diagnostic methods | |
AU2002227184A1 (en) | Methods for development and use of diagnostic and therapeutic agents | |
AU2002356530A1 (en) | Medical devices comprising nanomaterials and therapeutic methods utilizing the same | |
HK1115537A1 (en) | A use of hydroalcoholic gel in the manufacture of medicine | |
AU6019898A (en) | Devices for tissue repair and methods for preparation and use thereof | |
AU2002219229A1 (en) | Means for the diagnosis and therapy of CTCL | |
AU2002308348A1 (en) | Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours | |
AU2001255241A1 (en) | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis | |
AU3159499A (en) | Antigen preparation and use | |
AU1164601A (en) | Therapeutic use and formulation | |
AU2002305811A1 (en) | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis | |
AU2002220744A1 (en) | T-cell epitope of the papillomavirus L1 and E7 protein and use thereof in diagnostics and therapy | |
AU4014700A (en) | Tuberculosis antigens and methods of use therefor | |
AU2001253886A1 (en) | Methylxanthines in the diagnosis and treatment of autistic disorder | |
AU6835300A (en) | Diagnostic kit and use thereof | |
AU5611701A (en) | Agent for the diagnosis and therapy of viral diseases | |
AU3153100A (en) | Gas analyser and the use thereof in medical diagnostics | |
AU2001272552A1 (en) | Oxygen-enriched agent and the use thereof for therapeutic purposes | |
AU2002228085A1 (en) | Utilization of a claudin-4 ligand and conjugates thereof in the therapy and diagnosis of tumors | |
WO2004039333A9 (en) | ANTIGENIC gp 100 COMPOUNDS FOR THERAPY AND DIAGNOSIS AND METHODS FOR USING SAME | |
GB0011125D0 (en) | Combined rapid diagnosis and therapy | |
AU2002364385A1 (en) | Implantable device and the use thereof | |
AUPR556601A0 (en) | Therapeutic and diagnostic molecules - II | |
GB9926811D0 (en) | Combined rapid diagnosis and therapy |